FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Federal Register

CDER Continues Quality Management Program

Federal Register notice: FDA seeks drug manufacturing establishments to participate in the second year of its voluntary Quality Management Maturity Pr...

latest-news-card-1
FDA General

FDA Integrity, Decision-Making at Risk: Blog

FDA Matters founder Steven Grossman says FDA commissioner Martin Makary and the Trump administration are at a crossroads and need to decide whether th...

latest-news-card-1
Human Drugs

ICH Q1 Stability Testing Guide Out for Comment

The International Council for Harmonization endorses and releases for comment its Q1 guidance on drug product stability testing.

latest-news-card-1
Human Drugs

FDA Alert on Compounded Topical Finasteride

FDA says it has received reports of adverse effects associated with using unapproved compounded topical finasteride products.

latest-news-card-1
Marketing

Drug Promotion Leaders Leave Agency

FDA Office of Prescription Drug Promotion director Catherine Gray and deputy director Mark Askine resign their posts in the wake of their Office havi...

latest-news-card-1
Medical Devices

QS Violations at Noah Medical Corporation

FDA warns San Jose, CA-based Noah Medical about Quality System violations in its manufacturing of the Galaxy System bronchoscopes and accessories.

latest-news-card-1
Human Drugs

Promising Enhertu+Perjeta Data in Breast Cancer

AstraZeneca and Daiichi Sankyo report interim data from a Phase 3 trial that showed Enhertu (trastuzumab deruxtecan), in combination with Perjeta pert...

FDA General

Lt. Governors Urge Trump to Support FDA, Other Agencies

The Democratic Lieutenant Governors Association writes president Donald Trump urging him to support and safeguard the integrity of key federal science...

latest-news-card-1
FDA General

AI in Regulatory Science: Conference Report

A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligence to meet new demand...

latest-news-card-1
Human Drugs

FDA Inspections Will Suffer Under FDA Cuts: Lawyers

Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity could slow drug approval...